Compare $MLYS vs $VERA | Chartloom

Compare

$MLYS vs $VERA

Mineralys Therapeutics Inc · Vera Therapeutics, Inc

MLYS

Mineralys Therapeutics Inc

VERA

Vera Therapeutics, Inc

Compare $MLYS vs $VERA

Comparing Mineralys Therapeutics Inc and Vera Therapeutics, Inc

MLYSMineralys Therapeutics Inc

VERAVera Therapeutics, Inc

MLYSMineralys Therapeutics Inc

Market cap

$2.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

30.20x

Rev growth (TTM)

—

YTD performance

-34.6%

52W performance

-37.7%

FCF yield

-16.5%

VERAVera Therapeutics, Inc

Market cap

$2.14B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.87x

Rev growth (TTM)

—

YTD performance

-38.5%

52W performance

-2.0%

FCF yield

-15.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MLYS

VERA

Detailed metrics comparison

MLYS

Mineralys Therapeutics Inc

VERA

Vera Therapeutics, Inc

Market Cap

MLYS$2.06B

VERA$2.14B

Enterprise Value

MLYS$2.02B

VERA$2.17B

Price

MLYS$23.37

VERA$29.88

P/E Ratio

MLYSN/A

VERAN/A

P/S Ratio

MLYS0.00x

VERA0.00x

EV/Sales

MLYS0.00x

VERA0.00x

EV/EBITDA

MLYS0.00x

VERA0.00x

P/B Ratio

MLYS3.79x

VERA5.38x

P/FCF Ratio

MLYSN/A

VERAN/A

EV/FCF

MLYS-5.96x

VERA-6.40x

PEG Ratio

MLYSN/A

VERAN/A

Forward P/E (NTM)

MLYSN/A

VERAN/A

Forward P/S (NTM)

MLYS30.20x

VERA19.87x

Revenue (TTM)

MLYS$0

VERA$0

Revenue Growth (YoY)

MLYSN/A

VERAN/A

Forward Rev Growth

MLYS106.7%

VERA698.6%

Gross Margin (TTM)

MLYS0.0%

VERA0.0%

Operating Margin (TTM)

MLYS0.0%

VERA0.0%

EBITDA Margin (TTM)

MLYS0.0%

VERA0.0%

Net Margin (TTM)

MLYS0.0%

VERA0.0%

FCF Margin (TTM)

MLYSN/A

VERAN/A

Net Income (TTM)

MLYS$-350M

VERA$-402M

FCF (TTM)

MLYS$-339M

VERA$-339M

EPS (TTM)

MLYS-$4.13

VERA-$5.59

ROE (TTM)

MLYS-5797.0%

VERA-8413.0%

ROA (TTM)

MLYS-5415.0%

VERA-6679.0%

ROIC (TTM)

MLYS-5571.0%

VERA-7272.0%

Cash

MLYS$138M

VERA$49M

Debt

MLYS$98M

VERA$75M

Net Cash/Debt

MLYS$41M

VERA$-26M

Current Ratio (TTM)

MLYS34.46x

VERA10.92x

Quick Ratio (TTM)

MLYS34.24x

VERA10.50x

Debt/Equity (TTM)

MLYS0.18x

VERA0.18x

Debt/Assets (TTM)

MLYS0.0%

VERA0.0%

Interest Coverage (TTM)

MLYSN/A

VERAN/A

Net Debt/EBITDA (TTM)

MLYS0.00x

VERA0.00x

Beta

MLYS0.64

VERA1.13

52W Performance

MLYS-37.7%

VERA-2.0%

YTD Performance

MLYS-34.6%

VERA-38.5%

% from 52W High

MLYS-51.0%

VERA-46.7%

% from 52W Low

MLYS8.9%

VERA29.6%

Asset Turnover (TTM)

MLYS0.00x

VERA0.00x

FCF Yield (TTM)

MLYS-16.5%

VERA-15.8%

Earnings Yield (TTM)

MLYS-17.0%

VERA-18.7%

Dividend Yield (TTM)

MLYSN/A

VERAN/A

Rule of 40

MLYS0.0

VERA0.0

EV/GP/RG

MLYSN/A

VERAN/A

Ticker research

View MLYS research View VERA research

Metric	MLYS Mineralys Therapeutics Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.06B	$2.14B
Enterprise Value	$2.02B	$2.17B
Price	$23.37	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.79x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.96x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	30.20x	19.87x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	106.7%	698.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-350M	$-402M
FCF (TTM)	$-339M	$-339M
EPS (TTM)	-$4.13	-$5.59
ROE (TTM)	-5797.0%	-8413.0%
ROA (TTM)	-5415.0%	-6679.0%
ROIC (TTM)	-5571.0%	-7272.0%
Financial Health
Cash	$138M	$49M
Debt	$98M	$75M
Net Cash/Debt	$41M	$-26M
Current Ratio (TTM)	34.46x	10.92x
Quick Ratio (TTM)	34.24x	10.50x
Debt/Equity (TTM)	0.18x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	1.13
52W Performance	-37.7%	-2.0%
YTD Performance	-34.6%	-38.5%
% from 52W High	-51.0%	-46.7%
% from 52W Low	8.9%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.5%	-15.8%
Earnings Yield (TTM)	-17.0%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MLYS research	View VERA research

Valuation

P/S Ratio

MLYS

0.00x

VERA

0.00x

EV/FCF

VERA

-6.40x

MLYS

-5.96x

Growth & revenue

Forward Revenue Growth

VERA

698.6%

MLYS

106.7%

Profitability & performance

Gross Margin

MLYS

0.0%

VERA

0.0%

ROE

MLYS

-5797.0%

VERA

-8413.0%

FCF Yield %

VERA

-15.8%

MLYS

-16.5%

52-Week Performance

VERA

-2.0%

MLYS

-37.7%

Detailed metrics comparison

MLYS

Mineralys Therapeutics Inc

VERA

Vera Therapeutics, Inc

Market Cap

MLYS$2.06B

VERA$2.14B

Enterprise Value

MLYS$2.02B

VERA$2.17B

Price

MLYS$23.37

VERA$29.88

P/E Ratio

MLYSN/A

VERAN/A

P/S Ratio

MLYS0.00x

VERA0.00x

EV/Sales

MLYS0.00x

VERA0.00x

EV/EBITDA

MLYS0.00x

VERA0.00x

P/B Ratio

MLYS3.79x

VERA5.38x

P/FCF Ratio

MLYSN/A

VERAN/A

EV/FCF

MLYS-5.96x

VERA-6.40x

PEG Ratio

MLYSN/A

VERAN/A

Forward P/E (NTM)

MLYSN/A

VERAN/A

Forward P/S (NTM)

MLYS30.20x

VERA19.87x

Revenue (TTM)

MLYS$0

VERA$0

Revenue Growth (YoY)

MLYSN/A

VERAN/A

Forward Rev Growth

MLYS106.7%

VERA698.6%

Gross Margin (TTM)

MLYS0.0%

VERA0.0%

Operating Margin (TTM)

MLYS0.0%

VERA0.0%

EBITDA Margin (TTM)

MLYS0.0%

VERA0.0%

Net Margin (TTM)

MLYS0.0%

VERA0.0%

FCF Margin (TTM)

MLYSN/A

VERAN/A

Net Income (TTM)

MLYS$-350M

VERA$-402M

FCF (TTM)

MLYS$-339M

VERA$-339M

EPS (TTM)

MLYS-$4.13

VERA-$5.59

ROE (TTM)

MLYS-5797.0%

VERA-8413.0%

ROA (TTM)

MLYS-5415.0%

VERA-6679.0%

ROIC (TTM)

MLYS-5571.0%

VERA-7272.0%

Cash

MLYS$138M

VERA$49M

Debt

MLYS$98M

VERA$75M

Net Cash/Debt

MLYS$41M

VERA$-26M

Current Ratio (TTM)

MLYS34.46x

VERA10.92x

Quick Ratio (TTM)

MLYS34.24x

VERA10.50x

Debt/Equity (TTM)

MLYS0.18x

VERA0.18x

Debt/Assets (TTM)

MLYS0.0%

VERA0.0%

Interest Coverage (TTM)

MLYSN/A

VERAN/A

Net Debt/EBITDA (TTM)

MLYS0.00x

VERA0.00x

Beta

MLYS0.64

VERA1.13

52W Performance

MLYS-37.7%

VERA-2.0%

YTD Performance

MLYS-34.6%

VERA-38.5%

% from 52W High

MLYS-51.0%

VERA-46.7%

% from 52W Low

MLYS8.9%

VERA29.6%

Asset Turnover (TTM)

MLYS0.00x

VERA0.00x

FCF Yield (TTM)

MLYS-16.5%

VERA-15.8%

Earnings Yield (TTM)

MLYS-17.0%

VERA-18.7%

Dividend Yield (TTM)

MLYSN/A

VERAN/A

Rule of 40

MLYS0.0

VERA0.0

EV/GP/RG

MLYSN/A

VERAN/A

Ticker research

View MLYS research View VERA research

Metric	MLYS Mineralys Therapeutics Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.06B	$2.14B
Enterprise Value	$2.02B	$2.17B
Price	$23.37	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.79x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.96x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	30.20x	19.87x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	106.7%	698.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-350M	$-402M
FCF (TTM)	$-339M	$-339M
EPS (TTM)	-$4.13	-$5.59
ROE (TTM)	-5797.0%	-8413.0%
ROA (TTM)	-5415.0%	-6679.0%
ROIC (TTM)	-5571.0%	-7272.0%
Financial Health
Cash	$138M	$49M
Debt	$98M	$75M
Net Cash/Debt	$41M	$-26M
Current Ratio (TTM)	34.46x	10.92x
Quick Ratio (TTM)	34.24x	10.50x
Debt/Equity (TTM)	0.18x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	1.13
52W Performance	-37.7%	-2.0%
YTD Performance	-34.6%	-38.5%
% from 52W High	-51.0%	-46.7%
% from 52W Low	8.9%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.5%	-15.8%
Earnings Yield (TTM)	-17.0%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MLYS research	View VERA research